Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sapna P Patel

Showing results (21-30 of 125) with videos related to

Pageof 13
Sort By:
Journal for Immunotherapy of Cancer|March 12, 2022
The vaccine-site microenvironment: impacts of antigen, adjuvant, and same-site vaccination on antigen presentation and immune signalingMax O Meneveau, Pankaj Kumar, Kevin T Lynch, et al.
Pediatric Dermatology|October 21, 2009
Neonatal sporotrichosisBrook E Tlougan, Joshua O Podjasek, Sapna P Patel, et al.
Clinical Trials (London, England)|March 18, 2025
Design considerations for randomized comparisons of neoadjuvant-adjuvant versus adjuvant-only cancer immunotherapy when tumor measurement schedules do not align (SWOG S1801)Megan Othus, Elad Sharon, Michael C Wu, et al.
Journal of the American Academy of Dermatology|July 7, 2023
Minority enrollment in melanoma clinical trialsElena Paz Munoz, Sapna P Patel, Sancy A Leachman, et al.
Radiology|July 30, 2024
Intratumoral Injection of Immunotherapeutics: State of the Art and Future DirectionsRahul A Sheth, Eric Wehrenberg-Klee, Sapna P Patel, et al.
American Journal of Clinical Oncology|June 19, 2012
Delayed systemic recurrence of uveal melanomaNathalie A Kolandjian, Caimiao Wei, Sapna P Patel, et al.
Cancers|February 1, 2019
Adjuvant Ipilimumab in High-Risk Uveal MelanomaEric Fountain, Roland L Bassett, Suzanne Cain, et al.
Gynecologic Oncology|April 2, 2021
Immunotherapy combined with high- and low-dose radiation to all sites leads to complete clearance of disease in a patient with metastatic vaginal melanomaDuygu Sezen, Roshal R Patel, Christine Tang, et al.
Cancers|July 2, 2021
Metastatic Risk Factors Associated with Class 1A Uveal Melanoma PatientsAlexej Ballhausen, Elizabeth Urias, Stephen K Gruschkus, et al.
JAMA Dermatology|May 8, 2024
Keratosis Pilaris-Like Reaction Associated With Chromatin Remodeling Complex Inhibition in Uveal MelanomaRiyad N H Seervai, Madison M Taylor, Ziba Rahbar, et al.
Pageof 13

Showing results (21-30 of 125) with videos related to

Sort By:
Pageof 13
Journal for Immunotherapy of Cancer|March 12, 2022
The vaccine-site microenvironment: impacts of antigen, adjuvant, and same-site vaccination on antigen presentation and immune signalingMax O Meneveau, Pankaj Kumar, Kevin T Lynch, et al.
Pediatric Dermatology|October 21, 2009
Neonatal sporotrichosisBrook E Tlougan, Joshua O Podjasek, Sapna P Patel, et al.
Clinical Trials (London, England)|March 18, 2025
Design considerations for randomized comparisons of neoadjuvant-adjuvant versus adjuvant-only cancer immunotherapy when tumor measurement schedules do not align (SWOG S1801)Megan Othus, Elad Sharon, Michael C Wu, et al.
Journal of the American Academy of Dermatology|July 7, 2023
Minority enrollment in melanoma clinical trialsElena Paz Munoz, Sapna P Patel, Sancy A Leachman, et al.
Radiology|July 30, 2024
Intratumoral Injection of Immunotherapeutics: State of the Art and Future DirectionsRahul A Sheth, Eric Wehrenberg-Klee, Sapna P Patel, et al.
American Journal of Clinical Oncology|June 19, 2012
Delayed systemic recurrence of uveal melanomaNathalie A Kolandjian, Caimiao Wei, Sapna P Patel, et al.
Cancers|February 1, 2019
Adjuvant Ipilimumab in High-Risk Uveal MelanomaEric Fountain, Roland L Bassett, Suzanne Cain, et al.
Gynecologic Oncology|April 2, 2021
Immunotherapy combined with high- and low-dose radiation to all sites leads to complete clearance of disease in a patient with metastatic vaginal melanomaDuygu Sezen, Roshal R Patel, Christine Tang, et al.
Cancers|July 2, 2021
Metastatic Risk Factors Associated with Class 1A Uveal Melanoma PatientsAlexej Ballhausen, Elizabeth Urias, Stephen K Gruschkus, et al.
JAMA Dermatology|May 8, 2024
Keratosis Pilaris-Like Reaction Associated With Chromatin Remodeling Complex Inhibition in Uveal MelanomaRiyad N H Seervai, Madison M Taylor, Ziba Rahbar, et al.
Pageof 13